Spatial Biology for Drug Development Summit

Visit Flagship at the Spatial Biology for Drug Development Summit.
October 11-13, 2023. 

Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is becoming a crucial component of successful drug development programs.

We are your source for spatial biology expertise, moving forward your research and drug development programs every step of the way.  Meet with us at the Spatial Biology for Drug Development Summit to learn how our medical, analytical, and data science experts can partner with you for:

  • AI-powered digital pathology solutions
  • Immuno-oncology biomarker development and validation
  • Spatial biology and molecular diagnostics analysis
  • Immunotherapy clinical trial support
  • CDx development
  • Regulatory guidance
Tom Turi, Ph.D.

Tom Turi, Ph.D.

Chief Scientific Officer at Flagship Biosciences

Thursday, October 12, 2023 at 2:45 PM ET

Join Flagship CSO Tom Turi for his presentation, “Improving Clinical Trial Outcomes with Tissue Image Analysis: Case Studies:”

  • Increasing accuracy and yield of existing biomarker assays
  • Investigating spatial and image analysis solutions for patient selection
  • Expanding the use of spatial imaging applications beyond oncology

    The Digital Pathology Advantage

    • Improve ROI, accelerate trials, and minimize budget impacts
    • Minimize recruitment costs and other clinical trial expenses
    • Discover cost benefits of Flagship’s image analysis platform

    Driving Your Biomarker Strategy: Facts by numbers

    • View our resume and history to learn why Flagship is the premier partner for your study
    • See the full list of spatial biology services that empower confident clinical decision making
    • See the benefits with a fully integrated team of scientists and pathologists

    Validated Assays for Use in Immunotherapy Research & Development.

    • Customizable options optimized to your needs and validation requirements
    • Ability to create multiplex assays to characterize complex cellular interactions

    Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications

    • Expertise in novel biomarker and tissue analyses
    • Regulatory strategy and support
    • Consult with scientific experts

    Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

    Recent Posts

    2024 AACR Annual Meeting

    Are you attending the 2024 AACR Annual Meeting? Visit us at booth #910. Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in...

    Spatial Biology for Immuno-Oncology Summit 2024

    Meet with us at the Spatial Biology for Immuno-Oncology Summit.The Spatial Biology for Immuno-Oncology Summit is back for its second year, and Flagship Biosciences is a Program Partner for the event. Join us January 23-25 in San Diego where key industry leaders will...

    65th ASH Annual Meeting and Exposition

    Meet with us at the American Society of Hematology annual meeting in December. Whether you’re engaged in basic research or drug development, our genomics solutions offer valuable insights to help you achieve your goals. We offer the highest quality results and support...

    Society for Immunotherapy of Cancer Annual Meeting

    Visit Flagship at SITC 2023 Booth #716. November 3-5, 2023. We offer a comprehensive set of discovery, translational and clinical testing, and assay development services to support your clinical studies in immune-oncology and immunotherapy. From the selection of...

    13th Annual World Clinical Biomarkers & CDx Summit

    Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th Annual World Clinical Biomarkers & CDx...